personally, i haven't purchased any Cydy stock for several months because of the continued trajectory downward and the fact that shorts are absolutely dominant .
if a BTD for cancer is a go or the NASH topline report shows superior results, i'm jumping in for more shares because at that point, i believe the stock has bottomed and will work its way up. the data will also drive the partner conversations to a new level..